Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Red Fl...

    2025-11-04

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Red Fluorescent Reporter with Cap 1 Structure

    Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding the red fluorescent protein mCherry, optimized for high stability and low immunogenicity in mammalian systems. The Cap 1 structure, enzymatically added, mimics natural mammalian mRNA, enhancing translational efficiency (product page). Incorporation of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) suppresses innate immune activation and increases mRNA stability (Roach 2024). The mRNA is approximately 996 nucleotides long, supplied at ~1 mg/mL in 1 mM sodium citrate buffer, pH 6.4. A poly(A) tail further enhances translation initiation, making this product suitable for reporter gene applications and cellular localization studies. Storage at or below -40°C is required to maintain mRNA integrity.

    Biological Rationale

    Fluorescent protein reporters are essential in molecular and cellular biology for monitoring gene expression, protein localization, and cell tracking. mCherry is a monomeric red fluorescent protein (emission maximum ≈ 610 nm) derived from Discosoma's DsRed protein, widely used due to its brightness and photostability (Roach 2024). Synthetic mRNA systems offer non-integrative, transient expression, avoiding the risks associated with genomic integration. However, unmodified mRNA is susceptible to degradation by nucleases and can trigger innate immunity via pattern recognition receptors such as TLR7 and TLR8. Modifications such as Cap 1 capping and incorporation of 5mCTP and ψUTP reduce immunogenicity and improve translation efficiency, enabling more reliable fluorescent protein expression for demanding research workflows (see related for mechanistic distinctions).

    Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

    • Cap 1 Structure: The enzymatic addition of a Cap 1 structure (m7GpppNmp) using Vaccinia virus capping enzyme, GTP, S-adenosylmethionine, and 2´-O-Methyltransferase enhances ribosomal recognition and translation initiation. Cap 1 also mimics native mammalian mRNA, reducing recognition by innate immune sensors (product page).
    • 5mCTP and ψUTP Incorporation: Modified nucleotides 5-methylcytidine and pseudouridine are incorporated during in vitro transcription. These modifications decrease activation of TLR7/8 and RIG-I pathways, suppressing type I interferon responses and increasing mRNA half-life (Roach 2024).
    • Poly(A) Tail: The presence of a poly(A) tail enhances mRNA stability and translation by facilitating ribosome recruitment and protecting the mRNA from exonuclease degradation.
    • Buffer and Storage: Supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, the formulation supports long-term stability when stored at ≤ -40°C.

    Evidence & Benchmarks

    • Cap 1-modified mRNA demonstrates enhanced translational efficiency in mammalian cells compared to Cap 0 mRNA (Roach 2024).
    • 5mCTP and ψUTP modifications suppress innate immune activation, evidenced by reduced interferon-stimulated gene expression in vitro (Roach 2024).
    • mCherry protein expressed from modified mRNA retains emission maximum at ~610 nm, quantifiable by fluorescence microscopy or flow cytometry (Roach 2024).
    • EZ Cap™ mCherry mRNA (5mCTP, ψUTP) maintains functional stability when stored at or below -40°C for several months (product page).
    • Poly(A)-tailed, modified mRNA exhibits prolonged expression duration compared to unmodified, uncapped control mRNA in cell culture (see related).

    Applications, Limits & Misconceptions

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is designed for use as a reporter gene in molecular and cell biology, including:

    • Fluorescent labeling of live cells for localization and tracking studies.
    • Quantitative analysis of transfection efficiency in high-throughput screening.
    • Assessment of mRNA delivery vehicles (e.g., lipid nanoparticles, mesoscale nanoparticles).
    • Evaluation of mRNA stability and translation in primary or difficult-to-transfect cells.
    • Non-integrative, transient expression systems for safety-focused research.

    This article extends prior analyses such as EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Precision Tools for Fluorescent Protein Expression, by providing detailed, verifiable claims and explicit storage/handling parameters for practical laboratory use. For a broader perspective on next-generation reporter gene mRNA, see Next-Generation Reporter Gene mRNA: Mechanistic Advances, which contextualizes these molecular innovations within evolving translational workflows.

    Common Pitfalls or Misconceptions

    • Not a gene-editing tool: This product does not modify genomic DNA; it provides transient mRNA expression only.
    • Requires appropriate delivery system: Efficient cellular uptake depends on transfection method (e.g., electroporation, lipid nanoparticles).
    • Temperature sensitivity: Storage above -40°C can rapidly degrade the mRNA, reducing expression efficiency.
    • Not suitable for clinical use: For research use only; not for therapeutic administration or diagnostic procedures in humans or animals.
    • Cellular context matters: Expression efficiency and duration can vary significantly between cell types and experimental conditions.

    Workflow Integration & Parameters

    • Preparation: Thaw mRNA aliquots on ice; avoid repeated freeze-thaw cycles.
    • Transfection: Optimize delivery method for target cell type; lipid nanoparticles and electroporation are commonly used for mRNA transfection.
    • Detection: mCherry fluorescence is detectable with excitation at ~587 nm and emission at ~610 nm (Roach 2024).
    • Controls: Include unmodified or uncapped mRNA controls to benchmark expression and immune activation.
    • Storage: Store at or below -40°C in 1 mM sodium citrate, pH 6.4; aliquot for single use to avoid degradation.

    Conclusion & Outlook

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) exemplifies the evolution of reporter gene mRNA technologies by maximizing stability, translational efficiency, and immune evasion. Its Cap 1 structure, 5mCTP/ψUTP modifications, and rigorous quality standards support highly reproducible, long-lived fluorescent protein expression in diverse experimental systems (see product). Future advances may further improve delivery specificity and in vivo persistence, but current data establish this reagent as a benchmark for molecular cell biology research. For unique mechanistic insights and extended application contexts, see EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Redefining Precision, which details comparative advantages and imaging strategies beyond those summarized here.